メニュー
JP | JPY
-
-
- Challenges and Chances: A Review of the 1st Stem Cell Community Day
- Summertime, and the Livin’ Is Easy…
- Follow-on-Biologics – More than Simple Generics
- Bacteria Versus Body Cells: A 1:1 Tie
- Behind the Crime Scene: How Biological Traces Can Help to Convict Offenders
- Every 3 Seconds Someone in the World Is Affected by Alzheimer's
- HIV – It’s Still Not Under Control…
- How Many Will Be Convicted This Time?
- Malaria – the Battle is Not Lost
- Physicians on Standby: The Annual Flu Season Can Be Serious
- At the Forefront in Fighting Cancer
- Molecular Motors: Think Small and yet Smaller Again…
- Liquid Biopsy: Novel Methods May Ease Cancer Detection and Therapy
- They Are Invisible, Sneaky and Disgusting – But Today It’s Their Special Day!
- How Many Cells Are in Your Body? Probably More Than You Think!
- What You Need to Know about Antibiotic Resistance – Findings, Facts and Good Intentions
- Why Do Old Men Have Big Ears?
- The Condemned Live Longer: A Potential Paradigm Shift in Genetics
- From Research to Commerce
- Chronobiology – How the Cold Seasons Influence Our Biorhythms
- Taskforce Microbots: Targeted Treatment from Inside the Body
- Eyes on Cancer Therapy
-
-
-
-
-
- Challenges and Chances: A Review of the 1st Stem Cell Community Day
- Summertime, and the Livin’ Is Easy…
- Follow-on-Biologics – More than Simple Generics
- Bacteria Versus Body Cells: A 1:1 Tie
- Behind the Crime Scene: How Biological Traces Can Help to Convict Offenders
- Every 3 Seconds Someone in the World Is Affected by Alzheimer's
- HIV – It’s Still Not Under Control…
- How Many Will Be Convicted This Time?
- Malaria – the Battle is Not Lost
- Physicians on Standby: The Annual Flu Season Can Be Serious
- At the Forefront in Fighting Cancer
- Molecular Motors: Think Small and yet Smaller Again…
- Liquid Biopsy: Novel Methods May Ease Cancer Detection and Therapy
- They Are Invisible, Sneaky and Disgusting – But Today It’s Their Special Day!
- How Many Cells Are in Your Body? Probably More Than You Think!
- What You Need to Know about Antibiotic Resistance – Findings, Facts and Good Intentions
- Why Do Old Men Have Big Ears?
- The Condemned Live Longer: A Potential Paradigm Shift in Genetics
- From Research to Commerce
- Chronobiology – How the Cold Seasons Influence Our Biorhythms
- Taskforce Microbots: Targeted Treatment from Inside the Body
- Eyes on Cancer Therapy
-
-
-
JP | JPY
Sorry, we couldn't find anything on our website containing your search term.
- 2026 Award Finalist Dr. Martina Pacesa
2026 Award Winner: Dr. Martin Pačesa
Appointment at time of winninig the Award
Assistant Professor and Group Leader at University of Zurich, Institute of Pharmacology, Switzerland.
Martin Pačesa, born 1993, receives the € 20.000,-- award for his research on AI-guided de novo design of functional protein binders. The jury members were excited by his outstanding research and acknowledged the importance of his contributions to this field and the impact of the tools that he had developed for the research community.
Martin Pačesa: “It still feels a bit unreal to receive the 2026 Eppendorf Award for Young European Investigators. This recognition reflects our work on deep learning-based protein design, particularly BindCraft, which enables accurate and accessible design of protein binders. Much of biology can be framed as a binder-target problem, and the ability to design these interactions on demand opens new possibilities in biological research. I am grateful to my colleagues at EPFL, especially Prof. Bruno Correia, Lennart Nickel, and Christian Schellhaas, as well as to my wife, my new lab at the University of Zurich, and support from the ERC. There’s still a lot to figure out, but it feels like we’re moving towards a point where protein design can become genuinely routine for the everyday biologist.”
The official prize ceremony took place on July 16, 2026 at the Advanced Training Centre of the EMBL in Heidelberg. The laudation honoring Martin Pačesa‘s achievements was written by Award Jury Member Prof. Ben Lehner, Wellcome Sanger Institute, Cambridge, UK and CRG, Barcelona, Spain
Martin Pačesa, born 1993, receives the € 20.000,-- award for his research on AI-guided de novo design of functional protein binders. The jury members were excited by his outstanding research and acknowledged the importance of his contributions to this field and the impact of the tools that he had developed for the research community.
Martin Pačesa: “It still feels a bit unreal to receive the 2026 Eppendorf Award for Young European Investigators. This recognition reflects our work on deep learning-based protein design, particularly BindCraft, which enables accurate and accessible design of protein binders. Much of biology can be framed as a binder-target problem, and the ability to design these interactions on demand opens new possibilities in biological research. I am grateful to my colleagues at EPFL, especially Prof. Bruno Correia, Lennart Nickel, and Christian Schellhaas, as well as to my wife, my new lab at the University of Zurich, and support from the ERC. There’s still a lot to figure out, but it feels like we’re moving towards a point where protein design can become genuinely routine for the everyday biologist.”
The official prize ceremony took place on July 16, 2026 at the Advanced Training Centre of the EMBL in Heidelberg. The laudation honoring Martin Pačesa‘s achievements was written by Award Jury Member Prof. Ben Lehner, Wellcome Sanger Institute, Cambridge, UK and CRG, Barcelona, Spain
もっと読む
2026 Finalists
Dr. Sebastiaan De Schepper
VIB-Center for Molecular Neurology (CMN), Wilrijk, Belgium
Dr. Tanita Wein
Weizmann Institute of Science, Rehovot, Israel
VIB-Center for Molecular Neurology (CMN), Wilrijk, Belgium
Dr. Tanita Wein
Weizmann Institute of Science, Rehovot, Israel
もっと読む
PDF 0.14 MB
JPG 4.30 MB
PDF 0.75 MB
PDF 0.09 MB